The following companies are expected to report earnings prior to market open on 03/18/2024. Visit our Earnings Calendar for a full list of expected earnings releases.
Science Applications International Corporation (SAIC)is reporting for the quarter ending January 31, 2024. The information technology services company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.41. This value represents a 30.88% decrease compared to the same quarter last year. In the past year SAIC and beat the expectations the other two quarters. Zacks Investment Research reports that the 2024 Price to Earnings ratio for SAIC is 18.17 vs. an industry ratio of -4.80, implying that they will have a higher earnings growth than their competitors in the same industry.
Acurx Pharmaceuticals, Inc. (ACXP)is reporting for the quarter ending December 31, 2023. The biomedical (gene) company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.26. This value represents a 7.14% increase compared to the same quarter last year. ACXP missed the consensus earnings per share in the 4th calendar quarter of 2022 by -12%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for ACXP is -2.63 vs. an industry ratio of -2.60.
Exagen Inc. (XGN)is reporting for the quarter ending December 31, 2023. The medical products company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.41. This value represents a 29.31% increase compared to the same quarter last year. In the past year XGN and beat the expectations the other three quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for XGN is -1.19 vs. an industry ratio of 1.80.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
